Research ArticleDrug Delivery
First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip
- Robert Farra1,*,
- Norman F. Sheppard Jr.1,
- Laura McCabe1,
- Robert M. Neer2,
- James M. Anderson3,
- John T. Santini Jr.4,
- Michael J. Cima5 and
- Robert Langer6
- 1MicroCHIPS, Inc., Waltham, MA 02451, USA.
- 2Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
- 3Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
- 4On Demand Therapeutics Inc., Tyngsboro, MA 01879, USA.
- 5Department of Materials Science and Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- 6Department of Chemical Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- ↵*To whom correspondence should be addressed. E-mail: rfarra{at}mchips.com
See allHide authors and affiliations
Science Translational Medicine 22 Feb 2012:
Vol. 4, Issue 122, pp. 122ra21
DOI: 10.1126/scitranslmed.3003276
Vol. 4, Issue 122, pp. 122ra21
DOI: 10.1126/scitranslmed.3003276
Robert Farra
Norman F. Sheppard Jr.
Laura McCabe
Robert M. Neer
James M. Anderson
John T. Santini Jr.
Michael J. Cima